Peptide PilotPeptide Pilot
Download on the App Store

Comparison

Ipamorelin vs GHRP-2

Two ghrelin-mimetic GH releasers — selectivity profile and reported side-effect pattern read very differently in logs.

Download on the App StoreiPhone · Free to download
Field
Ipamorelin
GHRP-2
Category
GH Secretagogue
GH Secretagogue
Common alias
—
—
Example vial
2 mg + 2 mL BAC water
5 mg + 2 mL BAC water
Concentration
1.00 mg/mL
2.50 mg/mL
Example dose
0.2 mcg
0.1 mcg
Doses per week
7× / week
7× / week
Doses per vial (rounded down)
10
50
Approx vial duration
1.4 weeks
7.1 weeks

Ipamorelin and GHRP-2 both show up in the same conversations, but they aren't interchangeable. The table above lays the vial math side by side so you can see how concentration, doses-per-vial, and weekly cadence actually compare. The sections below walk through what each one is, how each is studied, and how each shows up in a tracked log — in plain English, no recommendations.

Tiebreakers

Where Ipamorelin and GHRP-2 actually diverge

IpamorelinGHRP-2
Cadence7/wk7/wk
Concentration on example1.00 mg/mL2.50 mg/mL
Math weeks per vial1.47.1
CategoryGH SecretagogueGH Secretagogue

Bolded values are the higher of the two on numeric rows. Same-value rows aren't a verdict — they're shared properties.

Ipamorelin vs GHRP-2: the actual decision

Both of these molecules are GHRPs — synthetic ghrelin-receptor agonists that trigger a pituitary GH pulse — but the comparison most readers come here to make is selectivity. Ipamorelin is the most receptor-selective of the common GHRPs; GHRP-2 is more potent at the GH-release endpoint but pulls cortisol, prolactin, and appetite along with it. The trade is structural: more pulse for more downstream noise, or a quieter pulse with a cleaner side-effect profile.

In a log, that selectivity difference shows up as different fields. Ipamorelin logs typically score the GH pulse signal alone — sleep quality, recovery, the small fasting blood-glucose movements that some readers track. GHRP-2 logs typically also score appetite (the ghrelin-mimetic effect is more pronounced) and an estimated cortisol-pattern proxy via mood and morning energy. Neither molecule needs every field, but choosing the wrong field set during cycle planning makes the data unreadable in retrospect.

Mechanism, cadence, and what shows up in a log

Cadence is similar between the two molecules — both are administered two-to-three times daily because both have short half-lives on the order of an hour or two. Per-dose milligrams are also in the same general range (100 mcg ipamorelin and 100–200 mcg GHRP-2 are common per-administration doses), which means the unit count on a 100-unit syringe at the same vial concentration is in the same neighborhood. The mg-to-units calculator linked below handles either once your vial is set.

GH-pulse magnitude is where GHRP-2 has the larger published number, but the more interesting log signal is how well each molecule pairs with a GHRH-side peptide like CJC-1295 or sermorelin. Ipamorelin pairs cleanly because its lack of cortisol or prolactin movement keeps the stack signal isolated to GH. GHRP-2 pairs with a noisier signal, which can be useful when appetite is a desired log variable and unhelpful when it is not.

Ipamorelin vs GHRP-2: the numbers, side by side

Start with what actually goes into a syringe. The example Ipamorelin vial on this site reconstitutes 2 mg in 2 mL of bacteriostatic water — about 1.00 mg per mL, which yields roughly 10 doses at the 200 mcg example and lasts about 1.4 weeks at 7 doses per week. The example GHRP-2 vial reconstitutes 5 mg in 2 mL (2.50 mg/mL), which yields about 50 doses at 100 mcg and stretches roughly 7.1 weeks at 7 doses per week. Those numbers are the starting point most people forget to write down, and they decide everything downstream — refill timing, unit count on the syringe barrel, and whether a 30-mL bac-water bottle stretches across one vial or two.

Category context matters too. Both Ipamorelin and GHRP-2 sit in the GH Secretagogue bucket, so the head-to-head questions readers bring here are usually about cadence, titration step size, and which of the two molecules logs more cleanly inside a longer protocol rather than a from-scratch category choice. Cadence helps frame the rest: Ipamorelin is logged about 7× per week in the example schedule, GHRP-2 about 7×.

The single most-asked-about mistake on each page is worth surfacing here, because they rarely overlap. On the Ipamorelin side: Administering doses at inconsistent times of day, which compromises the ability to observe long-term trends related to its selective action. On the GHRP-2 side: Mistaking GHRP-2 for GHRP-6 and failing to account for the documented differences in their side-effect profiles regarding appetite stimulation and prolactin. Both are the kind of thing a tracked log catches early and an untracked routine catches late.

Top Ipamorelin question
What is the primary distinction between Ipamorelin and GHRP-6?

The defining distinction is selectivity. Ipamorelin was developed specifically to stimulate growth hormone release with high potency while avoiding the significant increases in appetite, cortisol, and prolactin that are characteristic of older secretagogues like GHRP-6. This targeted action results from its refined molecular structure and specific binding profile.

Top GHRP-2 question
How is GHRP-2 structurally different from GHRP-6?

GHRP-2 is a synthetic hexapeptide with the sequence D-Ala-D-2-Nal-D-Trp-D-Phe-Lys-NH2. It was developed as a second-generation evolution of GHRP-6. The primary structural difference is the substitution of the natural L-Alanine found in GHRP-6 with a synthetic D-Alanine residue. This single amino acid change significantly alters the molecule’s interaction with the ghrelin receptor, giving rise to its different selectivity profile.

The calculator pages linked below let you swap your own vial size, diluent volume, and dose into the same math — these example numbers exist so the comparison renders with concrete figures instead of placeholders.

Frequently asked questions about Ipamorelin vs GHRP-2

What is the primary distinction between Ipamorelin and GHRP-6?
The defining distinction is selectivity. Ipamorelin was developed specifically to stimulate growth hormone release with high potency while avoiding the significant increases in appetite, cortisol, and prolactin that are characteristic of older secretagogues like GHRP-6. This targeted action results from its refined molecular structure and specific binding profile.
Why is Ipamorelin often studied in combination with CJC-1295 without DAC?
This combination is studied because it targets two separate pituitary receptors to synergistically amplify GH release. Ipamorelin acts on the ghrelin receptor while CJC-1295 (no DAC) acts on the GHRH receptor. Activating both pathways at once generates a more robust GH pulse than using either peptide alone, while still honoring the body's natural pulsatile rhythm.
How many units are required for a 200 mcg dose from a 2 mg vial reconstituted with 2 mL?
A 2 mg vial holds 2,000 micrograms of peptide. When reconstituted with 2 mL of bacteriostatic water, the final concentration becomes 1,000 mcg per mL. To draw a 200 mcg dose, you need 0.2 mL of the solution, which measures as exactly 20 units on a U-100 insulin syringe.
How is GHRP-2 structurally different from GHRP-6?
GHRP-2 is a synthetic hexapeptide with the sequence D-Ala-D-2-Nal-D-Trp-D-Phe-Lys-NH2. It was developed as a second-generation evolution of GHRP-6. The primary structural difference is the substitution of the natural L-Alanine found in GHRP-6 with a synthetic D-Alanine residue. This single amino acid change significantly alters the molecule’s interaction with the ghrelin receptor, giving rise to its different selectivity profile.
Why do studies describe GHRP-2 as more selective than GHRP-6?
In comparative scientific studies, GHRP-2 has been observed to stimulate a potent release of growth hormone while having a lesser impact on cortisol, prolactin, and appetite compared to dose-equivalent administrations of GHRP-6. This means its action is more focused on GH release. While it targets the same ghrelin receptor, its modified structure results in this more specific downstream effect, though it is still considered less selective than the third-generation peptide ipamorelin.
If a 5 mg vial of GHRP-2 is reconstituted with 2 mL of water, how many units are drawn for a 100 mcg dose?
When a 5 mg (5,000 mcg) vial is reconstituted with 2 mL of diluent, the final concentration becomes 2,500 mcg per mL. To calculate the volume for a 100 mcg dose, you divide the dose by the concentration: 100 mcg ÷ 2,500 mcg/mL equals 0.04 mL. On a U-100 insulin syringe, 0.04 mL corresponds to exactly 4 units.

Related on Peptide Pilot

Log Ipamorelin and GHRP-2 side by side in the app

Download on the App StoreiPhone · Free · No credit card
Download on theApp Store→